BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3493035)

  • 1. [The role of the immunoglobin G "hinge" region in heat aggregation and activation of complex-formation].
    Khristoforov VS; Persanov VM; Sukhomudrenko AG; Abramov VM; Zav'ialov VP
    Biofizika; 1987; 32(1):32-6. PubMed ID: 3493035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Theoretical and experimental studies on the conformation of the hinge regions in human immunoglobulin G subclasses].
    Denesiuk AI; Tishchenko VM; Abramov VM; Zav'ialov VP
    Mol Biol (Mosk); 1983; 17(6):1262-71. PubMed ID: 6656755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
    Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
    Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.
    Kilchherr E; Schumaker VN; Bianchino AC; Curtiss LK
    J Immunol; 1987 Feb; 138(3):849-55. PubMed ID: 3492535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the structural-functional properties of immunoglobulins G and their fragments using 1H-NMR].
    Khristoforov VS; Kutyshenko VP; Zav'ialov VP
    Bioorg Khim; 1987 Nov; 13(11):1446-64. PubMed ID: 3327502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the biological functions of monoclonal immunoglobulins and their fragments.
    Kraj M; Cieśluk S; Rezmer M; Bragiel I; Snigurowicz J
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):297-312. PubMed ID: 7447642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two possible conformations of the repetitive site of the immunoglobulin G3 hinge region].
    Pirtskhalava MK; Poroĭkov VV; Tumanian VG
    Bioorg Khim; 1983 Sep; 9(9):1220-30. PubMed ID: 6333243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the structural and conformational basis for the relative resistance of serum and secretory immunoglobulin A to proteolysis.
    Underdown BJ; Dorrington KJ
    J Immunol; 1974 Mar; 112(3):949-59. PubMed ID: 4855821
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of C1q with beta 2-microglobulin.
    Björck L; Johnson U; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation of the hinge region and various fragments of human IgG3.
    Johnson PM; Michaelsen TE; Scopes PM
    Scand J Immunol; 1975; 4(2):113-9. PubMed ID: 1145126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement subcomponent C1q in rheumatic diseases].
    Yonemasu K; Sasaki T
    Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical, immunologic and therapeutic aspects of endangiitis obliterans].
    Lambrecht R; Heinrich P; Ladetzki HH; Morenz J
    Z Gesamte Inn Med; 1988 Sep; 43(18):511-4. PubMed ID: 2974223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.